SEMHF - Siemens Healthineers AG (SEMHF) Q3 2025 Earnings Call Transcript
2025-07-30 06:59:08 ET
Siemens Healthineers AG (SEMHF)
Q3 2025 Earnings Conference Call
July 30, 2025 02:30 AM ET
Company Participants
Bernhard Montag - President, CEO & Chairman of Management Board
Jochen Schmitz - CFO & Member of Management Board
Marc Koebernick - Head of Investor Relations
Conference Call Participants
David James Adlington - JPMorgan Chase & Co, Research Division
Edward Nicholas Ridley-Day - Redburn (Europe) Limited, Research Division
Falko Friedrichs - Deutsche Bank AG, Research Division
Graham Doyle - UBS Investment Bank, Research Division
Hassan Al-Wakeel - Barclays Bank PLC, Research Division
Hugo Solvet - BNP Paribas Exane, Research Division
Julien Dormois - Jefferies LLC, Research Division
Julien Ouaddour - BofA Securities, Research Division
Oliver Metzger - ODDO BHF Corporate & Markets, Research Division
Oliver Reinberg - Kepler Cheuvreux, Research Division
Richard Felton - Goldman Sachs Group, Inc., Research Division
Robert John Davies - Morgan Stanley, Research Division
Veronika Dubajova - Citigroup Inc., Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Siemens Healthineers conference call.
As a reminder, this conference is being recorded.
Before we begin, I would like to draw your attention to the safe harbor statement on Page 2 of the Siemens Healthineers presentation. This conference call may include forward-looking statements. These statements are based on the company's current expectations and certain assumptions and are, therefore, subject to certain risks and uncertainties.
At this time, I would like to turn the call over to your host today, Mr. Marc Koebernick, Head of Investor Relations. Please go ahead, sir....
Siemens Healthineers AG (SEMHF) Q3 2025 Earnings Call Transcript